CARDIOGEVITY

Serial Number 98582875
688

Registration Progress

Application Filed
Jun 4, 2024
Under Examination
Mar 11, 2025
Approved for Publication
Jan 14, 2025
Published for Opposition
Jan 14, 2025
Registered

Attorney Assistance

Important Deadline Approaching

Notice of Allowance Mailed - SOU Required
Due: September 11, 2025 (66 days remaining)

Missing this deadline could result in abandonment or cancellation of your trademark.

Basic Information

Serial Number
98582875
Deadline
September 11, 2025
Description
Statement of Use or 1st Extension Due
Filing Date
June 4, 2024
Published for Opposition
January 14, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
688
Status Date
Mar 11, 2025
Application
Pending
Classes
005 042

Rights Holder

Rejuvenation Technologies Inc.

03
Address
415 Clyde Ave. Unit 107
Mountain View, CA 94043

Ownership History

Rejuvenation Technologies Inc.

Original Applicant
03
Mountain View, CA

Rejuvenation Technologies Inc.

Owner at Publication
03
Mountain View, CA

USPTO Deadlines

Next Deadline
66 days remaining
Notice of Allowance Mailed - SOU Required
Due Date
September 11, 2025
Extension Available
Until March 11, 2026

Application History

8 events
Date Code Type Description
Mar 11, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 14, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 14, 2025 PUBO A PUBLISHED FOR OPPOSITION
Jan 8, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 20, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 16, 2024 DOCK D ASSIGNED TO EXAMINER
Dec 15, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 4, 2024 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Nutraceuticals for the treatment of or prevention of diseases and conditions related to short telomeres; Nutraceuticals for the treatment of or prevention of diseases and conditions of aging; Nutraceuticals for the treatment of or prevention of diseases and conditions of the heart; Pharmaceutical preparations for the treatment of or prevention of diseases and conditions related to short telomeres; Pharmaceutical preparations for the treatment of or prevention of diseases and conditions of aging; Pharmaceutical preparations for the treatment of heart conditions and diseases
Class 042
Research and development in the field of biotechnology; Research and development of medicines

Classification

International Classes
005 042